APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Product

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Selected research

Industry Growth & Trends

Global Blood Product Industry Growth and Trends Forecast to 2032

1 January 2026120 pages

Choose your research edition.

Industry ResearchBlood Product Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Product Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Blood Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Product Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Product Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

According to APO Research, the global Blood Product market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Blood Product market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Blood Product market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Blood Product market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Blood Product.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Blood Product market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Blood Product Market by Company

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

Shanghai RAAS

China Biologic Products

Hualan Biological Engineering Inc.

Beijing Tiantan Biological Products Corp

Pacific Shuanglin

Boya Bio-Pharmaceutical

Paisi Feike Biology Pharmacy Co., Ltd.

Xinjiang Deyuan Bioengineering

Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.

Shenzhen Weiguang

Shanxi Kangbao

Nanyue Biopharming Corporation Ltd

Blood Product Segment by Type

Albumin

Immunoglobulin

Clotting Factor

Others

Blood Product Segment by Application

Bleeding Wound

Immunodeficiency

HBV

Tetanus

Rabies

Hemophilia

Others

Blood Product Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Blood Product companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Blood Product Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Blood Product Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Blood Product Market Share by Region (2021-2026) Table 4. Global Blood Product Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Blood Product Market Share by Region (2027-2032) Table 6. Global Blood Product Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Blood Product Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Blood Product Market Size Share by Type (2021-2026) Table 9. Global Blood Product Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Blood Product Market Size Share Forecasted by Type (2027-2032) Table 11. North America Blood Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Blood Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Blood Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Blood Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Blood Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Blood Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Blood Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Blood Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Blood Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Blood Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Blood Product Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Blood Product Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Blood Product Market Size Share by Application (2021-2026) Table 24. Global Blood Product Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Blood Product Market Size Share Forecasted by Application (2027-2032) Table 26. North America Blood Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Blood Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Blood Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Blood Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Blood Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Blood Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Blood Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Blood Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Blood Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Blood Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Blood Product Industry Trends Table 37. Blood Product Industry Drivers Table 38. Blood Product Industry Opportunities and Challenges Table 39. Blood Product Industry Restraints Table 40. Global Blood Product Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Blood Product Revenue Market Share by Company (2021-2026) Table 42. Global Blood Product Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Blood Product Key Company Headquarters & Area Served Table 44. Global Blood Product Company, Product Type & Application Table 45. Global Blood Product Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Company Information Table 49. Takeda Business Overview Table 50. Takeda Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Blood Product Product Portfolio Table 52. Takeda Recent Development Table 53. CSL Company Information Table 54. CSL Business Overview Table 55. CSL Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. CSL Blood Product Product Portfolio Table 57. CSL Recent Development Table 58. Grifols Company Information Table 59. Grifols Business Overview Table 60. Grifols Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Grifols Blood Product Product Portfolio Table 62. Grifols Recent Development Table 63. Octapharma Company Information Table 64. Octapharma Business Overview Table 65. Octapharma Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Octapharma Blood Product Product Portfolio Table 67. Octapharma Recent Development Table 68. Kedrion Company Information Table 69. Kedrion Business Overview Table 70. Kedrion Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Kedrion Blood Product Product Portfolio Table 72. Kedrion Recent Development Table 73. LFB Group Company Information Table 74. LFB Group Business Overview Table 75. LFB Group Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. LFB Group Blood Product Product Portfolio Table 77. LFB Group Recent Development Table 78. Biotest Company Information Table 79. Biotest Business Overview Table 80. Biotest Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Biotest Blood Product Product Portfolio Table 82. Biotest Recent Development Table 83. BPL Company Information Table 84. BPL Business Overview Table 85. BPL Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. BPL Blood Product Product Portfolio Table 87. BPL Recent Development Table 88. Shanghai RAAS Company Information Table 89. Shanghai RAAS Business Overview Table 90. Shanghai RAAS Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Shanghai RAAS Blood Product Product Portfolio Table 92. Shanghai RAAS Recent Development Table 93. China Biologic Products Company Information Table 94. China Biologic Products Business Overview Table 95. China Biologic Products Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. China Biologic Products Blood Product Product Portfolio Table 97. China Biologic Products Recent Development Table 98. Hualan Biological Engineering Inc. Company Information Table 99. Hualan Biological Engineering Inc. Business Overview Table 100. Hualan Biological Engineering Inc. Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Hualan Biological Engineering Inc. Blood Product Product Portfolio Table 102. Hualan Biological Engineering Inc. Recent Development Table 103. Beijing Tiantan Biological Products Corp Company Information Table 104. Beijing Tiantan Biological Products Corp Business Overview Table 105. Beijing Tiantan Biological Products Corp Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Beijing Tiantan Biological Products Corp Blood Product Product Portfolio Table 107. Beijing Tiantan Biological Products Corp Recent Development Table 108. Pacific Shuanglin Company Information Table 109. Pacific Shuanglin Business Overview Table 110. Pacific Shuanglin Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Pacific Shuanglin Blood Product Product Portfolio Table 112. Pacific Shuanglin Recent Development Table 113. Boya Bio-Pharmaceutical Company Information Table 114. Boya Bio-Pharmaceutical Business Overview Table 115. Boya Bio-Pharmaceutical Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Boya Bio-Pharmaceutical Blood Product Product Portfolio Table 117. Boya Bio-Pharmaceutical Recent Development Table 118. Paisi Feike Biology Pharmacy Co., Ltd. Company Information Table 119. Paisi Feike Biology Pharmacy Co., Ltd. Business Overview Table 120. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Product Portfolio Table 122. Paisi Feike Biology Pharmacy Co., Ltd. Recent Development Table 123. Xinjiang Deyuan Bioengineering Company Information Table 124. Xinjiang Deyuan Bioengineering Business Overview Table 125. Xinjiang Deyuan Bioengineering Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Xinjiang Deyuan Bioengineering Blood Product Product Portfolio Table 127. Xinjiang Deyuan Bioengineering Recent Development Table 128. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information Table 129. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview Table 130. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Product Portfolio Table 132. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development Table 133. Shenzhen Weiguang Company Information Table 134. Shenzhen Weiguang Business Overview Table 135. Shenzhen Weiguang Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Shenzhen Weiguang Blood Product Product Portfolio Table 137. Shenzhen Weiguang Recent Development Table 138. Shanxi Kangbao Company Information Table 139. Shanxi Kangbao Business Overview Table 140. Shanxi Kangbao Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Shanxi Kangbao Blood Product Product Portfolio Table 142. Shanxi Kangbao Recent Development Table 143. Nanyue Biopharming Corporation Ltd Company Information Table 144. Nanyue Biopharming Corporation Ltd Business Overview Table 145. Nanyue Biopharming Corporation Ltd Blood Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Nanyue Biopharming Corporation Ltd Blood Product Product Portfolio Table 147. Nanyue Biopharming Corporation Ltd Recent Development Table 148. North America Blood Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Blood Product Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Blood Product Market Share by Country (2021-2026) Table 151. North America Blood Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Blood Product Market Share Forecast by Country (2027-2032) Table 153. Europe Blood Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Blood Product Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Blood Product Market Share by Country (2021-2026) Table 156. Europe Blood Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Blood Product Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Blood Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Blood Product Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Blood Product Market Share by Country (2021-2026) Table 161. Asia-Pacific Blood Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Blood Product Market Share Forecast by Country (2027-2032) Table 163. Latin America Blood Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Blood Product Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Blood Product Market Share by Country (2021-2026) Table 166. Latin America Blood Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Blood Product Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Blood Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Blood Product Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Blood Product Market Share by Country (2021-2026) Table 171. Middle East & Africa Blood Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Blood Product Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Blood Product Product Image Figure 3. Global Blood Product Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Blood Product Market Size (2021-2032) & (US$ Million) Figure 5. Global Blood Product Market Share by Region: 2025 VS 2032 Figure 6. Global Blood Product Market Share by Region (2021-2032) Figure 7. North America Blood Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Blood Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Blood Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Blood Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Blood Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Albumin Image Figure 13. Global Albumin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Immunoglobulin Image Figure 15. Global Immunoglobulin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Clotting Factor Image Figure 17. Global Clotting Factor Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Blood Product Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Blood Product Market Share by Type 2025 VS 2032 Figure 22. North America Blood Product Market Size Share by Type (2021-2032) Figure 23. Europe Blood Product Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Blood Product Market Size Share by Type (2021-2032) Figure 25. Latin America Blood Product Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Blood Product Market Size Share by Type (2021-2032) Figure 27. Bleeding Wound Image Figure 28. Global Bleeding Wound Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Immunodeficiency Image Figure 30. Global Immunodeficiency Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. HBV Image Figure 32. Global HBV Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Tetanus Image Figure 34. Global Tetanus Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Rabies Image Figure 36. Global Rabies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Hemophilia Image Figure 38. Global Hemophilia Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Others Image Figure 40. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Global Blood Product Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Blood Product Market Share by Application 2025 VS 2032 Figure 43. North America Blood Product Market Size Share by Application (2021-2032) Figure 44. Europe Blood Product Market Size Share by Application (2021-2032) Figure 45. Asia-Pacific Blood Product Market Size Share by Application (2021-2032) Figure 46. Latin America Blood Product Market Size Share by Application (2021-2032) Figure 47. Middle East and Africa Blood Product Market Size Share by Application (2021-2032) Figure 48. Global Top 5 and 10 Blood Product Players Market Share by Revenue in 2025 Figure 49. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 50. North America Blood Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. North America Blood Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. North America Blood Product Market Share by Country (2021-2032) Figure 53. Europe Blood Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Blood Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Blood Product Market Share by Country (2021-2032) Figure 56. Asia-Pacific Blood Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Asia-Pacific Blood Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Asia-Pacific Blood Product Market Share by Country (2021-2032) Figure 59. Latin America Blood Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Blood Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Blood Product Market Share by Country (2021-2032) Figure 62. Middle East & Africa Blood Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Middle East & Africa Blood Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 64. Middle East & Africa Blood Product Market Share by Country (2021-2032) Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Albumin
  • Immunoglobulin
  • Clotting Factor
  • Others
Applications
  • Bleeding Wound
  • Immunodeficiency
  • HBV
  • Tetanus
  • Rabies
  • Hemophilia
  • Others
Companies covered
  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • Shanghai RAAS
  • China Biologic Products
  • Hualan Biological Engineering Inc.
  • Beijing Tiantan Biological Products Corp
  • Pacific Shuanglin
  • Boya Bio-Pharmaceutical
  • Paisi Feike Biology Pharmacy Co., Ltd.
  • Xinjiang Deyuan Bioengineering
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
  • Shenzhen Weiguang
  • Shanxi Kangbao
  • Nanyue Biopharming Corporation Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Blood Product Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Blood Product Market Size by Region (2021-2032)
  5. 1.4.1 Global Blood Product Market Size by Region (2021-2026)
  6. 1.4.2 Global Blood Product Market Size by Region (2027-2032)
  7. 1.5 Key Regions Blood Product Market Size (2021-2032)
  8. 1.5.1 North America Blood Product Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Blood Product Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Blood Product Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Blood Product Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Blood Product Market Size Growth Rate (2021-2032)
2 Blood Product Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Albumin
  3. 2.1.2 Immunoglobulin
  4. 2.1.3 Clotting Factor
  5. 2.1.4 Others
  6. 2.2 Global Blood Product Market Size by Type
  7. 2.2.1 Global Blood Product Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Blood Product Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Blood Product Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Blood Product Market Size by Regions
  11. 2.3.1 North America Blood Product Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Blood Product Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Blood Product Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Blood Product Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Blood Product Market Size Breakdown by Type (2021-2026)
3 Blood Product Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Bleeding Wound
  3. 3.1.2 Immunodeficiency
  4. 3.1.3 HBV
  5. 3.1.4 Tetanus
  6. 3.1.5 Rabies
  7. 3.1.6 Hemophilia
  8. 3.1.7 Others
  9. 3.2 Global Blood Product Market Size by Application
  10. 3.2.1 Global Blood Product Market Size Overview by Application (2021-2032)
  11. 3.2.2 Global Blood Product Historic Market Size Review by Application (2021-2026)
  12. 3.2.3 Global Blood Product Market Size Forecasted by Application (2027-2032)
  13. 3.3 Global Blood Product Market Size by Regions
  14. 3.3.1 North America Blood Product Market Size Breakdown by Application (2021-2026)
  15. 3.3.2 Europe Blood Product Market Size Breakdown by Application (2021-2026)
  16. 3.3.3 Asia-Pacific Blood Product Market Size Breakdown by Application (2021-2026)
  17. 3.3.4 South America Blood Product Market Size Breakdown by Application (2021-2026)
  18. 3.3.5 Middle East and Africa Blood Product Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Blood Product Industry Trends
  2. 4.2 Blood Product Industry Drivers
  3. 4.3 Blood Product Industry Opportunities and Challenges
  4. 4.4 Blood Product Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Blood Product Revenue (2021-2026)
  2. 5.2 Global Blood Product Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Blood Product Key Company Headquarters & Area Served
  4. 5.4 Global Blood Product Company, Product Type & Application
  5. 5.5 Global Blood Product Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Blood Product Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Blood Product Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Blood Product Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Blood Product Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 CSL
  8. 6.2.1 CSL Company Information
  9. 6.2.2 CSL Business Overview
  10. 6.2.3 CSL Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 CSL Blood Product Product Portfolio
  12. 6.2.5 CSL Recent Developments
  13. 6.3 Grifols
  14. 6.3.1 Grifols Company Information
  15. 6.3.2 Grifols Business Overview
  16. 6.3.3 Grifols Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Grifols Blood Product Product Portfolio
  18. 6.3.5 Grifols Recent Developments
  19. 6.4 Octapharma
  20. 6.4.1 Octapharma Company Information
  21. 6.4.2 Octapharma Business Overview
  22. 6.4.3 Octapharma Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Octapharma Blood Product Product Portfolio
  24. 6.4.5 Octapharma Recent Developments
  25. 6.5 Kedrion
  26. 6.5.1 Kedrion Company Information
  27. 6.5.2 Kedrion Business Overview
  28. 6.5.3 Kedrion Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Kedrion Blood Product Product Portfolio
  30. 6.5.5 Kedrion Recent Developments
  31. 6.6 LFB Group
  32. 6.6.1 LFB Group Company Information
  33. 6.6.2 LFB Group Business Overview
  34. 6.6.3 LFB Group Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 LFB Group Blood Product Product Portfolio
  36. 6.6.5 LFB Group Recent Developments
  37. 6.7 Biotest
  38. 6.7.1 Biotest Company Information
  39. 6.7.2 Biotest Business Overview
  40. 6.7.3 Biotest Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Biotest Blood Product Product Portfolio
  42. 6.7.5 Biotest Recent Developments
  43. 6.8 BPL
  44. 6.8.1 BPL Company Information
  45. 6.8.2 BPL Business Overview
  46. 6.8.3 BPL Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 BPL Blood Product Product Portfolio
  48. 6.8.5 BPL Recent Developments
  49. 6.9 Shanghai RAAS
  50. 6.9.1 Shanghai RAAS Company Information
  51. 6.9.2 Shanghai RAAS Business Overview
  52. 6.9.3 Shanghai RAAS Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Shanghai RAAS Blood Product Product Portfolio
  54. 6.9.5 Shanghai RAAS Recent Developments
  55. 6.10 China Biologic Products
  56. 6.10.1 China Biologic Products Company Information
  57. 6.10.2 China Biologic Products Business Overview
  58. 6.10.3 China Biologic Products Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 China Biologic Products Blood Product Product Portfolio
  60. 6.10.5 China Biologic Products Recent Developments
  61. 6.11 Hualan Biological Engineering Inc.
  62. 6.11.1 Hualan Biological Engineering Inc. Company Information
  63. 6.11.2 Hualan Biological Engineering Inc. Business Overview
  64. 6.11.3 Hualan Biological Engineering Inc. Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Hualan Biological Engineering Inc. Blood Product Product Portfolio
  66. 6.11.5 Hualan Biological Engineering Inc. Recent Developments
  67. 6.12 Beijing Tiantan Biological Products Corp
  68. 6.12.1 Beijing Tiantan Biological Products Corp Company Information
  69. 6.12.2 Beijing Tiantan Biological Products Corp Business Overview
  70. 6.12.3 Beijing Tiantan Biological Products Corp Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Beijing Tiantan Biological Products Corp Blood Product Product Portfolio
  72. 6.12.5 Beijing Tiantan Biological Products Corp Recent Developments
  73. 6.13 Pacific Shuanglin
  74. 6.13.1 Pacific Shuanglin Company Information
  75. 6.13.2 Pacific Shuanglin Business Overview
  76. 6.13.3 Pacific Shuanglin Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Pacific Shuanglin Blood Product Product Portfolio
  78. 6.13.5 Pacific Shuanglin Recent Developments
  79. 6.14 Boya Bio-Pharmaceutical
  80. 6.14.1 Boya Bio-Pharmaceutical Company Information
  81. 6.14.2 Boya Bio-Pharmaceutical Business Overview
  82. 6.14.3 Boya Bio-Pharmaceutical Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Boya Bio-Pharmaceutical Blood Product Product Portfolio
  84. 6.14.5 Boya Bio-Pharmaceutical Recent Developments
  85. 6.15 Paisi Feike Biology Pharmacy Co., Ltd.
  86. 6.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Information
  87. 6.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
  88. 6.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Product Portfolio
  90. 6.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
  91. 6.16 Xinjiang Deyuan Bioengineering
  92. 6.16.1 Xinjiang Deyuan Bioengineering Company Information
  93. 6.16.2 Xinjiang Deyuan Bioengineering Business Overview
  94. 6.16.3 Xinjiang Deyuan Bioengineering Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Xinjiang Deyuan Bioengineering Blood Product Product Portfolio
  96. 6.16.5 Xinjiang Deyuan Bioengineering Recent Developments
  97. 6.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
  98. 6.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Product Portfolio
  102. 6.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Shenzhen Weiguang
  104. 6.18.1 Shenzhen Weiguang Company Information
  105. 6.18.2 Shenzhen Weiguang Business Overview
  106. 6.18.3 Shenzhen Weiguang Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Shenzhen Weiguang Blood Product Product Portfolio
  108. 6.18.5 Shenzhen Weiguang Recent Developments
  109. 6.19 Shanxi Kangbao
  110. 6.19.1 Shanxi Kangbao Company Information
  111. 6.19.2 Shanxi Kangbao Business Overview
  112. 6.19.3 Shanxi Kangbao Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Shanxi Kangbao Blood Product Product Portfolio
  114. 6.19.5 Shanxi Kangbao Recent Developments
  115. 6.20 Nanyue Biopharming Corporation Ltd
  116. 6.20.1 Nanyue Biopharming Corporation Ltd Company Information
  117. 6.20.2 Nanyue Biopharming Corporation Ltd Business Overview
  118. 6.20.3 Nanyue Biopharming Corporation Ltd Blood Product Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Nanyue Biopharming Corporation Ltd Blood Product Product Portfolio
  120. 6.20.5 Nanyue Biopharming Corporation Ltd Recent Developments
7 North America
  1. 7.1 North America Blood Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Blood Product Market Size by Country (2021-2026)
  3. 7.3 North America Blood Product Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Blood Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Blood Product Market Size by Country (2021-2026)
  3. 8.3 Europe Blood Product Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Blood Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Blood Product Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Blood Product Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Blood Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Blood Product Market Size by Country (2021-2026)
  3. 10.3 South America Blood Product Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Blood Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Blood Product Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Blood Product Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst